BioScience Health Innovations, Inc.
NOTR
$9.01
-$0.99-9.90%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.49% | 49.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.49% | 49.14% | |||
| Cost of Revenue | 83.00% | 100.81% | |||
| Gross Profit | -20.18% | 36.82% | |||
| SG&A Expenses | -10.69% | 56.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.16% | 66.76% | |||
| Operating Income | -82.21% | -24.26% | |||
| Income Before Tax | -82.21% | -24.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -82.21% | -24.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -82.21% | -24.26% | |||
| EBIT | -82.21% | -24.26% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -84.62% | -27.78% | |||
| Normalized Basic EPS | -87.50% | -27.27% | |||
| EPS Diluted | -84.62% | -27.78% | |||
| Normalized Diluted EPS | -87.50% | -27.27% | |||
| Average Basic Shares Outstanding | 1.33% | 1.19% | |||
| Average Diluted Shares Outstanding | 5.33% | 1.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||